<DOC>
	<DOCNO>NCT01132274</DOCNO>
	<brief_summary>Radiofrequency catheter ablation ( RFCA ) mainstay therapy supraventricular tachyarrhythmias , provide cure high percentage case . Conventional ablation technique require use fluoroscopy place navigate catheter heart , thus expose patient ionize radiation additional risk cancer . The feasibility safety non-fluoroscopic RFCA wide range supraventricular arrhythmia use EnSite NavX mapping system recently report . The NO-PARTY multicenter , randomized-controlled trial design test hypothesis supraventricular arrhythmias RFCA non-fluoroscopic EnSite NavX map system result clinically significant reduction exposure ionize radiation compare conventional ablation technique . NO-PARTY trial determine whether supraventricular tachyarrhythmia RFCA non-fluoroscopic EnSite NavX mapping system suitable cost-effective approach achieve clinically significant reduction ionize radiation exposure patient operator .</brief_summary>
	<brief_title>Radiation Exposure Reduction Supraventricular Tachycardia Ablation</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Supraventricular</mesh_term>
	<criteria>male female patient 14 50 year age receive indication radiofrequency catheter ablation supraventricular arrhythmia accord current guideline . atrial fibrillation non isthmusdependent atrial flutter pregnancy hematological contraindication ionize radiation exposure presence complex congenital heart disease , cardiac surgery within 1 month enrollment</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Supraventricular arrhythmia catheter ablation</keyword>
</DOC>